NOTCH3 and ovarian carcinoma: Highlighting the possibility of targeting the upstream Notch regulators, an orphan receptor NR2F6 promoted the CSC phenotype and induced cisplatin resistance in epithelial ovarian cancer cells by interacting with Notch3 promoter, localizing p300 there, enriching histone acetylation, and enhancing Notch3 transcription.